Nobuharu Tamaki

Aug 15, 2024 | nature.com | Lung-Yi Mak |Ken Liu |Sakkarin Chirapongsathorn |Nobuharu Tamaki |Mara Teresa Panlilio |Rashid Lui | +5 more

AbstractGlobally, nearly half of deaths from cirrhosis and chronic liver diseases (CLD) and three-quarters of deaths from hepatocellular carcinoma (HCC) occur in the Asia-Pacific region. Chronic hepatitis B is responsible for the vast majority of liver-related deaths in the region. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common form of CLD, affecting an estimated 30% of the adult population.